X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Tim McClung

Tim McClung Tim is a director of policy & research at PhRMA.

Recent Posts

PhRMA member companies R&D investments hit record high in 2017 - $71.4 billion

By Tim McClung  |    August 9, 2018
PhRMA member companies invested $71.4 billion in research and development (R&D) in 2017, the highest level of investment on record, according to the 2018 PhRMA member annual survey, released in...   Read More

Biopharma leads sustained economic growth driven by IP-intensive industries

By Tim McClung  |    September 26, 2017
While the biopharmaceutical industry is the global leader in generating innovative medicines and technologies, lesser known is the industry’s central role in sustaining economic growth. A recent...   Read More

How Manufacturing Advances Can Help Make Medicines More Effective

By Tim McClung  |    May 26, 2015
When we think about innovation in medicine development, we often don’t picture assembly lines or the industrial manufacturing methods that create the tablets, capsules, injectables or I.V....   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates